Eroxon

Eroxon is owned by Ferring Pharmaceuticals, headquartered in Switzerland. No. The ultimate owner of Eroxon, Ferring Pharmaceuticals, is headquartered in Switzerland, not in the United States.

Ferring Pharmaceuticals is a global biopharmaceutical company specializing in reproductive medicine and women's health, urology, and gastroenterology. The company is headquartered in Saint-Prex, Switzerland, and operates in over 50 countries worldwide.